CURIGLIANO, GIUSEPPE

CURIGLIANO, GIUSEPPE  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 532 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
"Burned out" phenomenon of the testis in retroperitoneal seminoma 1-gen-2006 G. CuriglianoO. De CobelliM. RescignoF. De Braud + Article (author) -
"The only thing i know is that i know nothing": 5-fluorouracil in human milk 1-gen-2012 GIOVANNETTI, EMILIOCurigliano, G. + Article (author) -
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines 1-gen-2016 D. CardinaleG. CuriglianoPIEPOLI, MASSIMO + Article (author) -
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines : the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) 1-gen-2017 G. Curigliano + Article (author) -
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3) 1-feb-2017 G. Curigliano + Article (author) -
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 1-gen-2017 Curigliano, G. + Article (author) -
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 1-gen-2017 Curigliano, G + Article (author) -
4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study 1-gen-1998 Curigliano, Giuseppe + Article (author) -
4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4) 1-ago-2018 Curigliano, G. + Article (author) -
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) 1-gen-2020 Curigliano G. + Article (author) -
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer 2-gen-2019 Viale, GiuliaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer 1-gen-2018 C. CriscitielloG. CuriglianoG. Pruneri + Article (author) -
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases 1-gen-2014 G. PruneriG. VialeG. Curigliano + Article (author) -
A new approach to assess drug sensitivity in cells for novel drug discovery 1-apr-2018 L. MazzarellaG. Curigliano Article (author) -
A non-randomized dose-escalation phase i trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors 1-gen-2016 G. Curigliano + Article (author) -
A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC) 1-ott-2016 Curigliano, G. + Article (author) -
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, With or Without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer 1-gen-2021 Curigliano, Giuseppe + Article (author) -
A Phase I/II Study of Rovalpituzumab Tesirine in Combination With Nivolumab ± Ipilimumab in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer 1-gen-2021 Curigliano, Giuseppe + Article (author) -
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer 1-gen-2016 G. Curigliano + Article (author) -
A phase Ib dose-finding study of alpelisib (ALP; BYL719) and paclitaxel (PTX) in advanced solid tumors (aST) 1-ott-2016 Curigliano, G. + Article (author) -